With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.
Gene editing has moved from labs to real world trials as scientists tweak DNA to cure disease, boost resilience, and redesign ...
The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise ...
CRISPR-edited insulin cells restore natural insulin in a Type 1 diabetes patient without rejection or immunosuppressants, ...
Letter shared exclusively with The i Paper shows Britain is concerned about live animal exports, gene editing and foie gras ...
The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
When six infants around the world were diagnosed with an odd trio of symptoms (diabetes, epilepsy, and abnormally small heads ...
Scientists developed an epigenetic editing platform using CRISPRoff and CRISPRon to reprogram human T cells. Unlike ...
Dr. Tobias Bexte will share recent advances that overcome key barriers to making NK cell therapies safe, effective and widely ...
Researchers at the Texas A&M University Health Science Centre have uncovered a hidden mechanism that drives the growth of one of the most aggressive forms ...
Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms, leaving ...